In the present research, the effectiveness of the small-molecule PERK inhibitor LDN-0060609 was evaluated in the cellular experimental model of glaucoma using HTM cells derived from the juxtacanalicular and corneoscleral regions of the human eye. Here, EIF2AK3 is linked to glaucoma.